![IJNS | Free Full-Text | Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment IJNS | Free Full-Text | Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment](https://pub.mdpi-res.com/IJNS/IJNS-05-00020/article_deploy/html/images/IJNS-05-00020-g001.png?1597229469)
IJNS | Free Full-Text | Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
![Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - ScienceDirect Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0301472X20303568-fx1.jpg)
Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - ScienceDirect
![Biomedicines | Free Full-Text | Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease Biomedicines | Free Full-Text | Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease](https://pub.mdpi-res.com/biomedicines/biomedicines-11-02412/article_deploy/html/images/biomedicines-11-02412-g001.png?1693363428)
Biomedicines | Free Full-Text | Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease
![Study shows L-Glutamine is effective and safe in fighting sickle cell pain attacks - School of Medicine News - Wayne State University Study shows L-Glutamine is effective and safe in fighting sickle cell pain attacks - School of Medicine News - Wayne State University](https://news.wayne.edu/storage/files/glutamine-sickle-cell-5c82cfc3737d5.jpg)
Study shows L-Glutamine is effective and safe in fighting sickle cell pain attacks - School of Medicine News - Wayne State University
![Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease? - Tayyaba Rehan - 2022 - Health Science Reports - Wiley Online Library Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease? - Tayyaba Rehan - 2022 - Health Science Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/59bd860d-9adf-4018-8ac4-19161a6a3001/hsr2713-fig-0001-m.jpg)
Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease? - Tayyaba Rehan - 2022 - Health Science Reports - Wiley Online Library
![Current Landscape in the Pharmacotherapy of Sickle Cell Disease (SCD) - Pharmaceutical Society of Jamaica Current Landscape in the Pharmacotherapy of Sickle Cell Disease (SCD) - Pharmaceutical Society of Jamaica](https://psjjamaica.org/wp-content/uploads/2021/06/Points-of-Action-300x224.png)
Current Landscape in the Pharmacotherapy of Sickle Cell Disease (SCD) - Pharmaceutical Society of Jamaica
![l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0268960X21001314-gr3.jpg)
l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect
![Pharmacy | Free Full-Text | Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine Pharmacy | Free Full-Text | Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine](https://www.mdpi.com/pharmacy/pharmacy-10-00123/article_deploy/html/images/pharmacy-10-00123-g001-550.jpg)
Pharmacy | Free Full-Text | Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine
![Therapeutic strategies for sickle cell disease: towards a multi-agent approach | Nature Reviews Drug Discovery Therapeutic strategies for sickle cell disease: towards a multi-agent approach | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-018-0003-2/MediaObjects/41573_2018_3_Fig1_HTML.png)
Therapeutic strategies for sickle cell disease: towards a multi-agent approach | Nature Reviews Drug Discovery
![l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0268960X21001314-gr2.jpg)